MEDICINES CONTROL COUNCIL

Slides:



Advertisements
Similar presentations
UN-OHRLLS Ernest V, Mbuli, OHRLLS Consultant The benefits of an intergovernmental agreement for the Trans African Highway Summary Of OHRLLS study.
Advertisements

Genuine Use in the EU The view from OHIM. Legislative History Early Commission proposal proposed use in a substantial part of the Community Early Commission.
Basel Protocol on Liability Ratification József Kelemen Ministry of Environment and Water.
Singapore February 2001 Promoting Fair and Transparent Regulation in Securities Markets A Presentation to the APEC-OECD Co-operative Initiative on Regulatory.
Decisions of the Parties Related to Essential Use Nominations (EUNs) Ozone Secretariat 6 July 2008 Bangkok.
European Commission: 1 Air emissions from ships – and overview of European policy Progress amending EC sulphur in fuel directive to include MARPOL Annex.
Requirements and recommendations for sustainability Emmi Jozsa Senior Advisor Sustainability Swedish Energy Agency.
Introduction to PPDs Regulatory requirements and rationale.
1 What Is Child Welfare? Child Welfare in the United States Background for understanding the public child welfare system The Service Array Process National.
Workshop for Custom Committee, Almaty, Kazakhstan
History of the Other Work of the SACHDNC Alex R. Kemper, MD, MPH, MS September 22, 2011.
Law as an enterprise skill: ‘Intellectual property and project commercialisation in engineering enterprise’ Professor Jim Roach Design Computing & Engineering.
D OHA N EGOTIATIONS & I NDIA P resenters * E vgeniya Burova * M ohini Patel.
1 - 1 INTERNATIONAL FINANCE Lecture Overview of Lecture 2 Goal of the multinational corporation (MNC) Key theories (Comparative, Imperfect Markets.
The Pharmaceutical Industry in Turkey
1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.
Consultative meeting Registrar of Medicines & Pharmaceutical Industry Ms Mandisa Hela Medicines Regulatory Affairs Department of Health 4 September 2008.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
Directorate General for Energy and Transport European Commission Directorate General for Energy and Transport Regulation of electricity markets in the.
Legal developments in the Polish Power Sector Arkadiusz Krasnodębski.
SUPPORTING PARENTS IN EUROPE EU COUNCIL OF EUROPE.
1 Regulatory capacity building and principles of Collaboration Procedure between the WHO Prequalification Programme and NMRAs Milan Smid WHO Prequalification.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Monitoring and reporting: key issues to inform the break out discussions Andrew Farmer 19 November 2015 “Make it Work” Workshop Brussels.
Policy Plan on Asylum An integrated approach to the protection of refugees across the European Union June 2008.
European Aviation Safety Agency Head of Aircraft Product Certification
DOF has been taking charge of the Animal Feed Quality Control Act 1982 and additional 1999 (only aquafeeds) since 1992 The roles of DOF are ensuring that.
1 Rotterdam Convention and listing in Annex III. 2 Objective of the Convention To promote shared responsibility and cooperative efforts among Parties.
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines.
EU Regulation on type-approval of hydrogen vehicles HFCV GTR – 4th SGS meeting Tokyo, Japan, September 2008 Ferenc PEKÁR Automotive Industry Unit.
EU Legislation and Policy Developments in Relation to Asylum: A View from the European Council on Refugees and Exiles 6 October 2010.
The Transposition of the Falsified Medicines Directive – the UK story
Workshop on “EU Enlargement: Regulatory Convergence in Non-acceding Countries” Athens 7 – 8 November 2003 Regulatory Convergence and Technical Standards.
History.... Right up until 1998 the UK did not have a bill of rights giving its citizens rights to certain basic freedoms. However, as early as 1950 the.
ΜΕΤΑΣΥΛΛΕΚΤΙΚΗ ΦΥΣΙΟΛΟΓΙΑ ΕΡΓΑΣΤΗΡΙΟ 3. Μετασυλλεκτική Εργ3-Λιοσάτου Γ.2 ΒΙΟΛΟΓΙΚΟΙ ΠΑΡΑΓΟΝΤΕΣ ΠΟΥ ΕΠΗΡΕΑΖΟΥΝ ΤΗ ΦΘΟΡΑ ΤΩΝ ΟΠΩΡΟΚΗΠΕΥΤΙΚΩΝ Αναπνοή Η λειτουργία.
New legislation impacting IMP
National Health Strategy
Business and the internet
Author: Nurul Azyyati Sabri
IADSA Global Guide to Good Manufacturing Practice for Supplements
Annex III to BS/SC/PDF/A(2003)1
66 items – 70% of circulated products
Package of agreements annexed to the WTO Agreement
Overview of public participation in strategic decision-making in the UNECE area David Aspinwall.
4 - 8 November 2013 AIM relevant - Assembly conclusions
International Maritime Organization
Licensing Authorities
INSPIRE Implementing Rules
GSP for pharmaceutical products
Certification system for prepackages
Application of ISO/IEC Guide 21 to the ACFCRs
Federal Food Drug and Cosmetic Act 1938
Aquatic Facility Regulation and Guidance Reviews
EU legislation on noise emission in the environment by equipment for use outdoors: latest developments European Commission DG Internal Market, Industry,
اثرات گرمايش جهاني تغييرات آب و هوا، تأثيرات عميق و شديدي بر بسياري از عوامل اساسي موثر بر سلامت از جمله : آب، غذا، هوا و محيط زيست دارد كه اين مورد خود.
SCP in the 7th Environmental Action Programme
Determined to reach the target: the EC’s progress
ESF Technical Working Group Tallinn, 28 November 2017
By Daniel RASE, Eurostat
Recent Developments in Regional Accounts
Types of Brands Also known as producer brands
EPAN – eGovernment WG Welcome - Introduction
Commission proposal for a new LIFE Regulation CGBN meeting
RADIATION SAFETY GUIDES
Branding / Packaging Trivia
1st HALF nd HALF 2019 Plan is to release NudgeBet in the UK early 2019 and then look to license BuddyBet in US on a state by.
ආහාරවල සෞඛ්‍යාරක්ෂිතතාවය පිළිබඳව පොදු පිළීවෙත් (GMP) හැදින්වීම
Current situation with nation branding issues in Hungary
GMP REQUIREMENTS FOR THE PRODUCTION OF API (OVERVIEW OF GMP PART II)
Presentation transcript:

MEDICINES CONTROL COUNCIL MS M HELA

In order to further facilitate the removal of barriers to trade in medicinal products, to promote uniformity in licensing decisions and to ensure the maintaining of high standards of quality assurance in the development, manufacture and control of medicinal products the following Guide to Good Manufacturing Practice for Medicinal Products and its Annexes has been adopted. HISTORY In the late 1980s / early 1990s the PIC/S GMP Guide was taken over by the EU and further developed in close co-operation with PIC/S. Since that time, the EU and the PIC/S GMP Guides have been developed in parallel and whenever a change has been made to one, the other has been amended so that both Guides are practically identical. There are, however, some differences between the two Guides. These differences are the following: